| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Obstetrics and Gynecology (G.A.H., R.A.), and Medicine (R.A.), The University of Alabama at Birmingham, Birmingham, Alabama 35233
Address correspondence and requests for reprints to: Ricardo Azziz, M.D., The University of Alabama at Birmingham, Department of Obstetrics and Gynecology, 549 Old Hillman Building, 618 South 20th Street, Birmingham, Alabama 35233-7333.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In vitro preparations of adrenal tissues result in variable, but definite, amounts of architectural disruption. In turn, this disruption in cell-to-cell contact may alter the same adrenocortical biosynthetic processes that are being examined. We hypothesized that the extent of architectural disruption during tissue preparation would impact the in vitro production of steroids. To test this hypothesis we compared the in vitro production of cortisol (F), androstenedione (A4), dehydroepiandrosterone (DHA), and DHA sulfate (DHS) in fresh tissue preparations from human adrenals with increasing degrees of architectural disruption: tissue slices, tissue minces, and cell suspensions.
| Materials and Methods |
|---|
|
|
|---|
Adrenal glands from five donors were obtained with consent, through the Alabama Organ Center, and were used 14 h after procurement. These experiments were approved by the Institutional Review Board. Adherent fat was removed, and adrenals were cross-sectioned with scalpels down the longitudinal axis. Slices with approximately similar proportions of adrenal zonae were used (i.e. extreme head and tail sections omitted).
Intact slices, approximately 23 mm thick, were used (average wet weight = 0.12 gm). Similarly, 0.12 gm of adrenal slices were used for the preparation of minces and cell suspensions. Adrenal minces entailed mincing slices with scalpels into approximately 2 mm2 cubes. Cell suspensions entailed dispersing the mince of one slice (i.e. 0.12 gm) with 1.0 mg/mL collagenase (type I-A) and 0.1 mg/mL DNAse (Sigma Chemical Co., St. Louis, MO), at 37 C and 5% CO2 for 1 h; followed by mechanical disruption using plastic transfer pipets. The initial cell suspensions were then centrifuged (500 x g, 3 min, 4 C), the supernatant discarded, and the cellular pellets resuspended in 3 mL serum-free medium (10) in 12-well culture clusters. Similarly, slices and minces were placed in 3 mL serum-free medium in 12-well culture clusters.
Time course studies and determination of cell viability and protein content
Adrenal tissue from one donor (female, age 17 yr) was used to examine the time course (20 min, 1, 3, 9 hr; n = 2) of steroid production of each tissue preparation. The incubation reactions were initiated by the addition of 10 µM pregnenolone substrate (Steraloids, Wilton, NH) to each tissue preparation and immediately placing these in a humidified culture incubator at 37 C and 5% CO2. Additional incubations were conducted (0.33, 9 hr; n = 2) to determine cell viability and protein content. For cell viability determinations, slice and mince preparations were reduced to cellular suspensions at the end of each incubation period as described above, and resuspended in the original incubation media. An aliquot of each of these cellular suspensions (corresponding to the original tissue preparation) was mixed with a 0.3% trypan blue solution (11) and 5% FCS; cell viability was determined by using an improved Neubauer hemacytometer. To determine protein content, the tissue preparations at the end of each incubation period were reduced to a conventional subcellular fraction (12) by homogenization in 0.3 M sucrose on ice, filtering through cheesecloth, then centrifugation (8000 x g, 10 min, 4 C). Protein content was estimated using the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA).
Comparison of steroid production by slices, minces, and cell suspensions
Comparison of steroid production among the three tissue preparations was conducted using adrenals from three males and one female (age range 2543 yr). Incubations for each donor were performed in triplicate, ± 1 µM ACTH-(124) (Organon, Bedford, OH) for 6 h. At the end of each incubation period the media was removed from slice and mince preparations, snap frozen in liquid nitrogen to terminate steroid metabolism, and stored at -70 C. For cell suspension preparations, the entire incubation volume (i.e. cell suspension and incubation media) was removed, and the cellular pellet and incubation media separated as described above. The incubation media (supernatant) was then snap-frozen and stored.
Determination of steroid levels
Stored incubation media was thawed, centrifuged (15, 600 x g, 5 min, 4 C) to remove cellular debris, and the supernatant used to determine steroid levels. DHA and F were determined using antibody-coated tube kits from Diagnostic Products Corporation (Los Angeles, CA). DHS and A4 were determined using liquid phase double antibody and antibody-coated tube kits, respectively, from Diagnostics Systems Laboratories, Inc. (Webster, TX). As these assays are designed for measurement of steroids in human serum, the incubation media samples were diluted or concentrated as necessary to ensure extrapolation of steroid values from the linear portion of the standard curve. Intra- and interassay coefficients of variance for control sample ligands 1, 2, and 3, from Chiron Diagnostics (East Walpole, MA), and pooled human serum were less than 5% and 10%, respectively.
Statistical analysis
The data shown for the time course incubations represent the mean steroid levels from duplicate incubations from a single donor. As such, these results are described in terms of apparent trends without statistical analysis. The data of the comparison between the three different tissue preparations (6-h incubations) represent the mean ± SD steroid levels from all incubations, conducted in triplicate using tissues from four donors. Significant differences in steroid levels among tissue preparations (either with or without ACTH) were determined by ANOVA with Fishers protected least significant difference test (PLSD) (P < 0.05).
| Results |
|---|
|
|
|---|
For all steroids (Fig. 1
, production
either peaked or plateaued at between 1 and 3 h. DHS (Fig. 1A
) and
DHA (Fig. 1C
) production decreased thereafter in some preparations;
i.e. DHA and DHS production decreased at 1 h in slices,
DHS production decreased at 1 h in minces, and DHA production
decreased in cell suspensions after 3 h. No such decrease in
production was observed for either F (Fig. 1B
) or A4 (Fig. 1D
).
|
Cell viability was similar among slices, minces, and cell suspensions, with 92.1%, 94.6%, and 93.0% mean viability at 20 min, and 90.2%, 92.2%, and 91.9% mean viability at 9 h, respectively. Protein content was generally similar between slices, minces, and cell suspensions, with a mean concentration of 36 mg/dL, 38 mg/dL, and 34 mg/dL at 20 min, and 37 mg/dL, 37 mg/dL, and 35 mg/dL at 9 h.
Comparison of steroid production by slices, minces, and cell suspensions
In the time course experiment using tissue from one donor, DHS
(Fig. 1A
) and F (Fig. 1B
) production was similar among slices and
minces and at least two-fold greater in cell suspensions. DHA
production increased steadily over time in mince preparations while
decreasing after 1 and 3 h in slice and cell suspension
preparations, respectively (Fig. 1C
). Similarly, A4 production was
greater in minces compared with either slice or cell suspension
preparations (Fig. 1D
).
In the single time point experiments using tissues from multiple
donors, as expected, addition of ACTH to the incubation reaction caused
increased production of all steroids compared with the corresponding
basal incubations (Fig. 2
). DHS
production was the most sensitive to changes in tissue preparation:
increasing with increasing tissue disruption, i.e. slices
less than minces less than suspensions (Fig. 2A
, mean values =
0.88 vs. 2.1 vs. 3.0 mg/gm tissue, respectively,
P < 0.0001). The production of F (Fig. 2B
) and A4
(Fig. 2D
) were higher in minces compared to either slices or
suspensions (mean values = 25.6 vs. 37.7 vs.
18.7 mg/gm tissue, respectively, P < 0.0028; and 254
vs. 709 vs. 456 ng/gm tissue, P
< 0.0042, respectively). The production of DHA was similar among all
preparations (Fig. 2C
). Age- or gender-specific differences in steroid
levels were not evident.
|
| Discussion |
|---|
|
|
|---|
Conceivably, the diffusion barriers inherent in each tissue preparation would limit the entry of the substrate (and any other potential regulatory factors including stimulators and inhibitors) into the tissue, and thus limit the enzymatic conversion of the substrate into the measured products. Such diffusion barriers are conceptually the lowest in cellular suspensions, followed by tissue minces, and highest for tissue slices. Thus, the total amount of steroid produced should be inversely proportional to the diffusion barrier. However, this trend was observed only for DHS. While the levels of A4 and F were higher in adrenal minces, compared to slices, the production of these steroids again decreased with further tissue disruption. The bimodal response of A4 and F may reflect the impact of two separate inhibitory effects, namely the decreased diffusion of pregnenolone into the tissue slices and the progressive inhibition of 3ß-HSD activity as cell-to-cell contact is lost.
Cumulative changes in steroid production (i.e. time course
incubations), particularly the substantial decrease in DHA at 3 h
in slice preparations, may represent one or more mechanisms influencing
steroidogenesis. First, a generalized decay in cellular steroidogenesis
may be most marked in slices, perhaps secondary to inadequate
oxygenation and utilization of nutrients by more centrally located
cells. However, this mechanism is unlikely as only DHA and DHS
decrease, while A4 and F continue to rise in slice preparations.
Secondly, the measured end products may be metabolized to other
steroids, which increase after the first hour of incubation. This is
also unlikely as there is not a corresponding increase in the
concentration of A4 (a DHA product) after the first hour of incubation.
Thirdly, an initial rapid release of DHA and DHS from tissue slices,
perhaps due to cell death at the periphery, is followed by
equilibration. Again, this is unlikely, as similar effects are not seen
for A4 and F. Overall it appears that only DHA and DHS production are
inhibited over time, with little effect on F or A4. This steroidogenic
picture may result from inhibition of the
517,20-lyase
activity of P450c17. As reported previously, adrenocortical
417,20-lyase activity (i.e. the direct
production of A4 from 17-hydroxy-progesterone) is minimal in the human
(13). Furthermore, in vivo studies have shown that acute
stress or trauma results in a similar steroidogenic pattern,
i.e. the inhibition of DHA and DHS secretion, although F
levels continue to rise (14). It is postulated that this alteration in
steroidogenesis is the result of altered P450c17 function. Likewise,
the adrenal slice, as the most intact of the preparations used, may
exhibit this stress response. If so, these data would suggest that
maintenance of cell-to-cell contact plays an important role in the
regulation of P450c17 activity.
The changes in adrenocortical steroidogenesis due to tissue disruption in vitro might suggest a role for altered cell-to-cell signaling in some of the physiopathologic alterations noted in vivo, for example, the decline in adrenal androgens noted with age (15). This hypothesis is supported by two findings. During human aging the boundary between the outer zona fasciculata and the inner zona reticularis becomes more diffuse as columns of the opposing zonal cell types begin to interdigitate across the zonal boundary (1, 16), thus suggesting a change in adrenocortical architecture. In addition, subjectively there is a dramatic age-related decrease in the overall consistency (texture) of the adrenal cortex, suggesting a loss in intercellular matrix (personal observation), although quantification of this process remains to be performed. Hence, physiologic changes in adrenal architecture could potentially represent a regulatory mechanism affecting adrenal steroid production.
Aside from the potential physicochemical discussion of the differences in steroid production, we must consider how these findings affect our knowledge of adrenocortical steroidogenesis. The majority of investigations of adrenocortical steroidogenesis have been accomplished using well-defined systems for monolayer cultures of either primary adrenal cell suspensions (5, 10) or adrenal carcinoma cell lines (17, 18). It is unclear to what extent these experiments reflect the actual steroidogenic processes in vivo. Although in situ adrenal studies likely provide more physiologically-relevant results, the results of in vitro studies do maintain some degree of cellular organization necessary for steroidogenesis (4) and do reflect some degree of steroidogenesis in vivo (19). Furthermore, the use of freshly prepared adrenal tissues is suggested to better reflect in vivo conditions compared to cell cultures (20). As noted previously, the functional activity of the human adrenal cortex is thought to depend upon the flow of steroids from one zone of the adrenocortical cells to the next and upon intraadrenal regulatory factors (2, 3). Obviously, the complex morphological architecture of the human adrenal cortex is completely lost under conditions of cell culture, acellular preparations, or dispersed cells. Hence, our data would suggest that, given sufficient donor adrenal tissue, the use of a tissue preparation that maintains some degree of overall tissue integrity, such as a tissue mince or slice, should be preferred.
We conclude that adrenocortical steroidogenesis is altered by changing
the degree of architectural disruption of the adrenal tissue.
Similarly, in an extensive review of glomerulosa function in rat
adrenals (21), increasing tissue disruption had differential effects on
aldosterone and corticosterone production in vitro. This
mechanical disruption, which is necessary to study steroidogenesis
in vitro, may impact the many physiological interactions
within the adrenal gland (e.g. innervation, immune and
endothelial cells, peptide growth factors, gap junctions) that are
involved in the regulation of adrenocortical steroidogenesis (3).
Nonetheless, at the gross tissue level, increasing tissue disruption
appears to favor sulfotransferase activity in vitro and,
depending on the time of incubation, either increases or decreases
3ß-HSD and
517,20-lyase activities: although this
remains to be confirmed molecularly. Moreover, the use of in
vitro systems for the study of adrenocortical steroidogenesis that
result in a significant loss of normal architecture may preclude
observing differences in steroidogenesis that are the result of
physiopathological alterations in cell-to-cell signaling. These results
underscore the need for carefully considering technical aspects of
in vitro adrenocortical studies, particularly when comparing
results between reports using different modes of tissue
preparation.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received July 17, 1998.
Revised December 14, 1998.
Accepted January 5, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Reisch, M. Slawik, O. Zwermann, F. Beuschlein, and M. Reincke Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion Eur. J. Endocrinol., November 1, 2005; 153(5): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Yildiz, K. S. Woods, F. Stanczyk, A. Bartolucci, and R. Azziz Stability of Adrenocortical Steroidogenesis over Time in Healthy Women and Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5558 - 5562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Azziz, L. M. Fox, H. A. Zacur, C. R. Parker Jr., and L. R. Boots Adrenocortical Secretion of Dehydroepiandrosterone in Healthy Women: Highly Variable Response to Adrenocorticotropin J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2513 - 2517. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |